Meritage Portfolio Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$211K Buy
+2,003
New +$188K 0.01% 303
2025
Q2
Sell
-2,650
Closed -$238K 337
2025
Q1
$238K Sell
2,650
-51,572
-95% -$4.82M 0.02% 302
2024
Q4
$5.39M Buy
54,222
+18,688
+53% +$1.93M 0.33% 77
2024
Q3
$4.04M Sell
35,534
-1,498
-4% -$178K 0.25% 124
2024
Q2
$4.58M Sell
37,032
-1,399
-4% -$180K 0.29% 111
2024
Q1
$5.07M Sell
38,431
-2,103
-5% -$259K 0.32% 95
2023
Q4
$4.42M Buy
40,534
+299
+0.7% +$31K 0.29% 109
2023
Q3
$4.14M Sell
40,235
-616
-2% -$66.4K 0.31% 107
2023
Q2
$4.71M Buy
40,851
+1,526
+4% +$173K 0.33% 103
2023
Q1
$4.18M Buy
39,325
+890
+2% +$96.1K 0.31% 114
2022
Q4
$4.26M Buy
38,435
+1,681
+5% +$172K 0.33% 111
2022
Q3
$3.17M Buy
36,754
+2,303
+7% +$206K 0.26% 119
2022
Q2
$3.14M Buy
34,451
+543
+2% +$48.1K 0.24% 129
2022
Q1
$2.78M Buy
+33,908
New +$2.67M 0.17% 145
2021
Q4
Sell
-2,725
Closed -$205K 347
2021
Q3
$205K Sell
2,725
-25,088
-90% -$1.91M 0.01% 309
2021
Q2
$2.16M Buy
27,813
+25,026
+898% +$1.86M 0.13% 174
2021
Q1
$205K Sell
2,787
-22
-0.8% -$1.62K 0.01% 275
2020
Q4
$219K Sell
2,809
-25,077
-90% -$1.92M 0.02% 246
2020
Q3
$2.21M Sell
27,886
-3,023
-10% -$237K 0.2% 142
2020
Q2
$2.28M Sell
30,909
-16,775
-35% -$1.26M 0.22% 134
2020
Q1
$3.5M Sell
47,684
-230
-0.5% -$18.1K 0.48% 55
2019
Q4
$4.16M Buy
47,914
+652
+1% +$53.6K 0.37% 86
2019
Q3
$3.8M Buy
47,262
+1,001
+2% +$80.2K 0.36% 82
2019
Q2
$3.7M Buy
46,261
+304
+0.7% +$23.3K 0.38% 102
2019
Q1
$3.65M Sell
45,957
-38,587
-46% -$2.89M 0.37% 118
2018
Q4
$6.16M Sell
84,544
-1,605
-2% -$113K 0.7% 32
2018
Q3
$5.83M Sell
86,149
-1,022
-1% -$65.1K 0.53% 66
2018
Q2
$5.05M Sell
87,171
-7,267
-8% -$410K 0.49% 89
2018
Q1
$4.91M Buy
94,438
+104
+0.1% +$5.62K 0.47% 88
2017
Q4
$5.07M Buy
94,334
+15,348
+19% +$851K 0.49% 93
2017
Q3
$4.83M Sell
78,986
-819
-1% -$49.7K 0.47% 98
2017
Q2
$4.88M Sell
79,805
-2,148
-3% -$131K 0.5% 95
2017
Q1
$4.97M Sell
81,953
-4,288
-5% -$260K 0.52% 88
2016
Q4
$4.84M Sell
86,241
-2,062
-2% -$121K 0.53% 93
2016
Q3
$5.26M Buy
88,303
+424
+0.5% +$24.8K 0.58% 72
2016
Q2
$4.83M Sell
87,879
-3,940
-4% -$210K 0.54% 82
2016
Q1
$4.63M Buy
+91,819
New +$4.5M 0.52% 99

Other funds holding MRK

Meritage Portfolio Management's MRK Position: Q4 2025 in Review

Meritage Portfolio Management opened a new position in Merck (MRK) in Q4 2025: 2,003 shares worth $211K. The stake represents 0.01% of the portfolio and ranks #303 among its holdings. This is a return to the name: Meritage Portfolio Management previously reported a position in MRK as recently as Q1 2025.

Meritage Portfolio Management first reported a position in MRK in Q1 2016 and has held it in 37 quarters since. The position peaked at $6.16M in Q4 2018. 3,662 funds tracked by Wall St. Rank hold MRK as of Q4 2025.

  • Meritage Portfolio Management held 2,003 shares of Merck worth $211K as of Q4 2025.
  • Merck was a new Meritage Portfolio Management position in Q4 2025.
  • Merck made up 0.01% of Meritage Portfolio Management's portfolio in Q4 2025, its #303 holding.
  • Meritage Portfolio Management first reported a position in Merck in Q1 2016 and has held it in 37 quarters since.
  • Meritage Portfolio Management's Merck position peaked at $6.16M in Q4 2018.
  • 3,662 funds tracked by Wall St. Rank held Merck as of Q4 2025.

Based on Meritage Portfolio Management's 13F filing for Q4 2025, filed 27 Jan 2026.